Your session is about to expire
← Back to Search
Study Summary
This trial will focus on older adults who are candidates for cardiac or pulmonary rehabilitation and who are vulnerable, mildly or moderately frail. The goal is to see if stepped care, which includes traditional center-based rehabilitation as well as transportation-subsidized CBR, home-based telerehabilitation, and community health worker-supported home-based telerehabilitation, is more effective than treatment as usual.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- Your hearing problem makes it difficult for you to answer questions over the phone.My heart or lung condition is covered for rehab by insurance.You are not expected to live more than one year.My blood sugar levels are not higher than 400 mg/dl.I do not have any mental health issues that prevent me from understanding or following study instructions.I am over 60 years old.I have irregular heartbeats from the lower chambers of my heart.I am scheduled for surgery or a transplant.I have unstable chest pain.I have heart failure that is not well-managed.I do not have active inflammation of the heart.I have severe lung blood pressure or heart issues due to lung conditions.Your heart's resting position shows a displacement of more than 2mm.I have had fainting spells due to an irregular heartbeat.You have a severe heart block without a pacemaker.My oxygen levels are below 85% without extra oxygen or with my usual extra oxygen.I have been to lung or heart rehab in the last 2 years.I have had a severe asthma attack requiring hospital or ED visit in the last 3 months.I do not have a fever or any sudden illness.I experience severe shortness of breath during exercise that oxygen doesn't help.I do not have conditions like severe arthritis or liver/kidney diseases that prevent me from exercising.I do not have uncontrolled irregular heartbeats.My blood pressure drops significantly when I stand up, causing symptoms.I am considered vulnerable to moderately frail according to the Clinical Frailty Scale.Your blood pressure when you are not active is higher than 200mmHg.Your diastolic blood pressure when you are resting is higher than 100mmHg.I have severe heart valve symptoms.Your heart beats too fast, more than 120 times per minute, and it cannot be controlled.
- Group 1: Treatment as usual
- Group 2: Stepped Care
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
How many participants are being recruited for this research experiment?
"Indeed, clinicaltrials.gov has documented that this medical experiment is actively recruiting participants; the trial was posted on September 8th 2022 and last modified on October 19th 2022. Two sites are looking to enrol 120 patients."
Are there opportunities available for individuals to participate in this scientific experiment?
"Confirmed by clinicaltrials.gov, this study is presently recruiting participants for the trial that began on September 8th 2022 and was most recently modified on October 19th 2022."
What is the primary focus of this exploration?
"This long-term clinical trial seeks to measure Adherence as its primary outcome after a duration of three years. Secondary goals include quantifying Smoking via self-reported data, and utilizing NIH PROMIS CAT scales to evaluate Social Isolation and Depression/Sadness."
Who else is applying?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger